New Technologies for Improving and Controlling Product Quality, Expression, Timelines and Yield in Upstream Process Development
18th February 2020 | 11:30 IST/ 14:00PM Singapore Time | Niki Wong, Principal Research Scientist at AbbVie Operations Singapore Pte Ltd |BOOK FREE SEAT
Increasing product demands at competitive pricing drive the need for accelerated product approval timelines, with reduced manufacturing risks and costs. New technologies which can debottleneck upstream process development or improve manufacturability success in early phase process development, translate into cell culture processes with high yield and desired product quality. An overview of different strategies and recent perspectives in upstream process development will be presented.
Presented by Niki Wong, Principal Research Scientist at AbbVie Operations Singapore Pte Ltd
Niki Wong is currently the Principal Research Scientist heading the Global Technical Operations group in AbbVie Operations Singapore Pte Ltd, that oversees process development and tech transfer activities for biologics processes. She has spent 8 years in AbbVie/Abbott, with a prior role as the cell culture lead scientist in the same group. Her previous experience as a Research Scientist at the Bioprocessing Technology Institute, involved various aspects of bioprocessing research that resulted in co-authorship of 17 publications.